We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+6.79%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$517M
AUM Growth
+$36.9M
Cap. Flow
+$3.98M
Cap. Flow %
0.77%
Top 10 Hldgs %
68.36%
Holding
100
New
11
Increased
19
Reduced
50
Closed
6

Top Buys

Rank Stock Value
1
RKT icon
Rocket Companies
RKT
+$10.1M
2
OGN icon
Organon & Co
OGN
+$7.84M
3
BABA icon
Alibaba
BABA
+$6.31M
4
GILD icon
Gilead Sciences
GILD
+$5.65M
5
IBM icon
IBM
IBM
+$5M

Sector Composition

Rank Sector Weight
1 Financials 42.04%
2 Technology 14.06%
3 Energy 13.98%
4 Healthcare 12.2%
5 Consumer Staples 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
26
Eli Lilly
LLY
$1.06T
$3.93M 0.76%
17,110
-70
-0.4% -$14.1K
NXPI icon
27
NXP Semiconductors
NXPI
$56.4B
$3.92M 0.76%
19,035
-40,355
-68% -$8.09M
LOW icon
28
Lowe's Companies
LOW
$119B
$3.71M 0.72%
19,125
-85
-0.4% -$16.6K
MRK icon
29
Merck
MRK
$379B
$3.65M 0.71%
46,890
-2,240
-5% -$167K
BEN icon
30
Franklin Templeton
BEN
$17.8B
$3.16M 0.61%
98,762
-3,275
-3% -$106K
BTI icon
31
British American Tobacco
BTI
$124B
$3.16M 0.61%
80,307
+25,432
+46% +$996K
STNE icon
32
StoneCo
STNE
$2.29B
$2.88M 0.56%
42,871
-1,929
-4% -$125K
XHB icon
33
State Street SPDR S&P Homebuilders ETF
XHB
$1.41B
$2.84M 0.55%
38,791
-3,720
-9% -$275K
UTHR icon
34
United Therapeutics
UTHR
$22.2B
$2.55M 0.49%
14,212
-18,024
-56% -$3.43M
CSCO icon
35
Cisco
CSCO
$441B
$2.29M 0.44%
43,289
AAPL icon
36
Apple
AAPL
$4.56T
$2.25M 0.43%
16,400
+523
+3% +$67.8K
MO icon
37
Altria Group
MO
$115B
$2.19M 0.42%
46,039
+16,814
+58% +$826K
CAH icon
38
Cardinal Health
CAH
$55.5B
$1.89M 0.37%
33,115
+1,395
+4% +$81.5K
PEP icon
39
PepsiCo
PEP
$194B
$1.88M 0.36%
12,665
-100
-0.8% -$14.6K
WBA
40
DELISTED
Walgreens Boots Alliance
WBA
$1.54M 0.3%
29,277
-21
-0.1% -$1.13K
ASO icon
41
Academy Sports + Outdoors
ASO
$2.71B
$1.5M 0.29%
+36,492
New +$1.28M
DVN icon
42
Devon Energy
DVN
$51.8B
$1.47M 0.28%
50,255
-2,425
-5% -$62.7K
PSX icon
43
Phillips 66
PSX
$97B
$1.43M 0.28%
16,665
-320
-2% -$27K
PLTR icon
44
Palantir
PLTR
$424B
$1.13M 0.22%
42,994
-57,186
-57% -$1.32M
SWKS icon
45
Skyworks Solutions
SWKS
$9.85B
$1.09M 0.21%
5,709
-2,798
-33% -$496K
JPM icon
46
JPMorgan Chase
JPM
$950B
$1.08M 0.21%
6,950
-100
-1% -$15.7K
CVX icon
47
Chevron
CVX
$394B
$1.02M 0.2%
9,715
+125
+1% +$13.2K
HON icon
48
Honeywell
HON
$69.5B
$923K 0.18%
4,467
-159
-3% -$33.6K
TSM icon
49
TSMC
TSM
$2.17T
$923K 0.18%
7,685
-1,845
-19% -$216K
BBL
50
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$907K 0.18%
15,200
-50
-0.3% -$3.06K

Similar funds

Greylin Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Greylin Investment Management held 100 positions worth $517M, up 7.7% from $480M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Greylin Investment Management's Q2 2021 filing shows 11 new, 19 increased, 50 reduced and 6 closed positions. Its largest new stake was Organon & Co: 238,225 shares worth $7.21M. The largest sale was NXP Semiconductors, an estimated $8.09M.

By sector, the portfolio is most concentrated in Financials at 42% of assets, up from 42% a quarter earlier, followed by Technology and Energy.

  • Greylin Investment Management's largest Q2 2021 buy was Organon & Co: 238,225 shares worth $7.21M.
  • Greylin Investment Management added most to Rocket Companies in Q2 2021, an estimated $10.1M increase.
  • Greylin Investment Management's biggest Q2 2021 reduction was NXP Semiconductors, cutting an estimated $8.09M.
  • Greylin Investment Management fully exited Simply Good Foods in Q2 2021, selling an estimated $711K.
  • Greylin Investment Management's ten largest holdings make up 68% of its $517M portfolio in Q2 2021.
  • Greylin Investment Management opened 11 new positions and closed 6 in Q2 2021.
  • Greylin Investment Management's portfolio value rose 7.7% quarter-over-quarter to $517M.

Based on Greylin Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.